Myriad Genetics to Release Second Quarter 2024 Financial Results on August 6, 2024
2024年7月30日 - 9:00PM
Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing
and precision medicine, will hold its second quarter earnings
conference call on Tuesday, August 6, 2024 at 4:30pm ET. The
company’s quarterly earnings will be released the same day after
the market closes.
During the call, Myriad management will provide a financial
overview and business update of the company’s performance for the
second quarter 2024.
A live webcast of the earnings conference call can be accessed
on Myriad’s Investor Relations website at investor.myriad.com. To
participate in the live conference call via telephone, please
register here. Upon registering, a dial-in number and unique PIN
will be provided to join the conference call. An archived webcast
of the call will be available at investor.myriad.com following the
call.
About Myriad GeneticsMyriad Genetics is a
leading genetic testing and precision medicine company dedicated to
advancing health and well-being for all. Myriad develops and offers
genetic tests that help assess the risk of developing disease or
disease progression and guide treatment decisions across medical
specialties where genetic insights can significantly improve
patient care and lower healthcare costs. For more information,
visit www.myriad.com.
Investor ContactMatt Scalo(801)
584-3532IR@myriad.com
Media ContactGlenn Farrell(385)
318-3718PR@myriad.com
Myriad Genetics (NASDAQ:MYGN)
過去 株価チャート
から 7 2024 まで 7 2024
Myriad Genetics (NASDAQ:MYGN)
過去 株価チャート
から 7 2023 まで 7 2024